Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases

View Full Paper

Ask AI

Bookmark

Immune activation patterns can distinguish patients with primary sclerosing cholangitis from those with inflammatory bowel disease.
Patients with primary sclerosing cholangitis showed increased levels of Th17 cells and decreased Tregs in circulation compared to controls.
Systematic review analyzed 23 articles involving 638 primary sclerosing cholangitis patients and 557 inflammatory bowel disease subjects.
Findings suggest unique immune profiles between primary sclerosing cholangitis and inflammatory bowel disease that may influence treatment approaches.

Discussion

No takes yet. Share an insight, caveat, or question.

Systematic review compares immune activation in primary sclerosing cholangitis and inflammatory bowel disease, highlighting significant differences.

Moniruzzaman et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review compares immune activation in primary sclerosing cholangitis and inflammatory bowel disease, highlighting significant differences.